Evidence map›Paper›PMID 30217896›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Interleukin-22 promotes phagolysosomal fusion to induce protection against

Jessica L Forbester, Emily A Lees, David Goulding, Sally Forrest, Amy Yeung, Anneliese Speak, Simon Clare, Eve L Coomber, Subhankar Mukhopadhyay, Judith Kraiczy and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Cross-Talk Between the Intestinal Epithelium andFrontiers in microbiology · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Infections in the monogenic autoimmune syndrome APECED.Current opinion in immunology · 2021
    Review
  18. Review
  19. IL10RB as a key regulator of COVID-19 host susceptibility and severity.medRxiv : the preprint server for health sciences · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Jessica L ForbesterInstitute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, United Kingdom; jf8@sanger.ac.uk.
Emily A LeesWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
David GouldingWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
Sally ForrestWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
Amy YeungWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
Anneliese SpeakWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.ORCID 0000-0003-4890-4685
Simon ClareWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
Eve L CoomberWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
Subhankar MukhopadhyayWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
Judith KraiczyDepartment of Paediatrics, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.ORCID 0000-0001-9073-6318
Fernanda SchreiberWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
Trevor D LawleyWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
Robert E W HancockCentre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Holm H UhligTranslational Gastroenterology Unit, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom.
Matthias ZilbauerDepartment of Paediatric Gastroenterology, Hepatology and Nutrition, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Fiona PowrieTranslational Gastroenterology Unit, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom.
Gordon DouganWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
Wellcome Sanger Institute · GBUniversity of Cambridge · GBJohn Radcliffe Hospital · GBUniversity of British Columbia · CA

Funding

Wellcome Trust
6 · The paper itself

Abstract

Intestinal epithelial cells (IECs) play a key role in regulating immune responses and controlling infection. However, the direct role of IECs in restricting pathogens remains incompletely understood. Here, we provide evidence that IL-22 primed intestinal organoids derived from healthy human induced pluripotent stem cells (hIPSCs) to restrict

Indexed as

Epithelial CellsHumansInduced Pluripotent Stem CellsInterleukin-10 Receptor beta SubunitInterleukin-21 Receptor alpha SubunitInterleukin-22InterleukinsIntestinal MucosaPhagosomesSalmonella InfectionsSalmonella typhimuriumIL10RB protein, humanIL21R protein, humanInterleukin-10 Receptor beta SubunitInterleukin-21 Receptor alpha SubunitInterleukin-22Interleukinsinterleukin-22intestinal organoidsSalmonella

Identifiers

PMID30217896
PMCPMC6176607
OpenAlexW2890108083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.